Back to Acrivon Therapeutics, Inc.

Acrivon Therapeutics, Inc.

All insiders

14 insiders

InsiderRole% of sharesShares heldLast trade
Blume-Jensen PeterPresident and CEO · Director5.59%2,394,331Mar 1, 2026
Devroe EricChief Operating Officer0.17%74,585Mar 1, 2026
Miller MaryChief Legal Officer0.08%33,679Mar 1, 2026
Levy Adam D.Chief Financial Officer0.05%20,983Mar 1, 2026
Gamelin ErickChief Development Officer0.03%14,812Mar 1, 2026
Magovcevic-Liebisch IvanaDirector0.02%9,366Jun 17, 2026
RA Capital Management, L.P.Director · 10% owner0.02%9,366Jun 17, 2026
Peterson KatharineChief Accounting Officer<0.01%4,006Mar 1, 2026
Kolchinsky PeterDirector · 10% owner
Masson KristinaEVP - Business Operations · Director
Mirza Mansoor RazaChief Medical OfficerMar 1, 2026
RA Capital Healthcare Fund LPDirector · 10% owner
RA Capital Nexus Fund II, L.P.Director
Shah Rajeev M.Director · 10% owner
← PrevPage 1 of 1Next →